FindTrial
Sign In

A Clinical Trial to Compare the Effects of Two Oral Drugs Prednisolone and Methylprednisolone in Patients of Acute Exacerbations of COPD.

Comparison of Efficacy of Oral Prednisolone with Oral Methylprednisolone in Patients with Acute Exacerbations of COPD.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025292
Enrollment
100
Registered
2020-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J441- Chronic obstructive pulmonary disease with (acute) exacerbation

Interventions

Intervention1: Comparison of effects of oral prednisolone with oral methylprednisolone in patients of Acute Exacerbations of COPD. : Oral Prednisolone 40 mg Once A Day for 5 days to Be Given To Patie

Sponsors

Dr Aditya Sharma
Lead Sponsor
Dr Sanjay Tandon
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients over 40 years of age diagnosed with A/E COPD.

Exclusion criteria

Exclusion criteria: Patients of COPD with pneumonia, COPD with pneumothorax Hospital stay less than 5 days, Patient with cardiac disease, History of asthma. Those not giving consent. Those unable to take oral corticosteroid.

Design outcomes

Primary

MeasureTime frame
Relief in Symptoms Timepoint: 5 days—

Secondary

MeasureTime frame
Length of hospital stay Treatment failure Adverse effects. Timepoint: 1 year—

Countries

India

Contacts

Public ContactDr Aditya Sharma

Peoples College of Medical Sciences And Research Centre

pulmedph@gmail.com9425030369

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026